Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2025-12-27 @ 9:38 PM
Study NCT ID:
NCT07077161
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-04
First Post:
2025-07-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cabozantinib Dose Skipping as an Alternative to Dose Reductions
Sponsor:
dr. Tom van der Hulle
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-08
First Submit QC Date:
None
Study First Post Date:
2025-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-27
Last Update Post Date:
2025-12-04
Last Update Post Date Type:
ESTIMATED